Recent studies in Chronic Lymphocytic Leukemia (CLL) have shown pronounced expression of GITRL and the GITR receptor was expressed at significantly higher levels on NK cells of CLL patients compared with healthy controls. This evidence concerns the gene TNFSF18 and B-cell chronic lymphocytic leukemia.